Search
for
Sort by
Research 61–90 of 427
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Cathelicidins: Opportunities and Challenges in Skin Therapeutics and Clinical Translation
- Inhaled Medicines for Targeting Non-Small Cell Lung Cancer
- Design and Characterization of Baricitinib Incorporated PLA 3D Printed Pills by Fused Deposition Modeling: An Oral Pill for Treating Alopecia Areata
- Phytochemicals for Hair Health Targeting Growth Signaling Molecules in Hair Follicular Stem Cells: A New Strategy for Hair Growth
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- Senotherapeutic Potential of Araliadiol in Senescent Human Dermal Fibroblasts: An In Vitro Study Using Three Senescence Models
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Immunopharmacological potential of Arctium lappa L. in immune-mediated skin diseases: A critical review of experimental and clinical evidence
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- First clinical cases of leishmaniosis in meerkats (Suricata suricatta) housed in wildlife parks in Madrid, Spain
- Recent Developments in Luteolin-Loaded Nanoformulations for Enhanced Anti-Carcinogenic Activities: Insights from In Vitro and In Vivo Studies
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Management of Older Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Mitoxantrone
- DRUG NEWS
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- Life threatening macrophage activation syndrome as the initial presentation of systemic lupus erythematosus: A case report and review of the literature
- Interferon in the treatment of cutaneous T-cell lymphoma
- Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
- First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
- Albendazole treatment of echinococcosis in humans: Effects on microsomal metabolism and drug tolerance
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Phase II Evaluation of VDC‐1101 in Canine Cutaneous T‐Cell Lymphoma
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”
- Complications associated with oncological therapy - how to minimize?
- Aldesleukin